Research ExplorerPublicationsRobotic-assisted minimally invasive Ivor Lewis esophagectomy...

Robotic-assisted minimally invasive Ivor Lewis esophagectomy within the prospective multicenter German da Vinci Xi registry trial

Standard

Robotic-assisted minimally invasive Ivor Lewis esophagectomy within the prospective multicenter German da Vinci Xi registry trial. / Egberts, Jan-Hendrik; Welsch, Thilo; Merboth, Felix; Korn, Sandra; Praetorius, Christian; Stange, Daniel E; Distler, Marius; Biebl, Matthias; Pratschke, Johann; Nickel, Felix; Müller-Stich, Beat; Perez, Daniel; Izbicki, Jakob R; Becker, Thomas; Weitz, Jürgen.

In: LANGENBECK ARCH SURG, Vol. 407, No. 4, 06.2022, p. 1-11.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Egberts, J-H, Welsch, T, Merboth, F, Korn, S, Praetorius, C, Stange, DE, Distler, M, Biebl, M, Pratschke, J, Nickel, F, Müller-Stich, B, Perez, D, Izbicki, JR, Becker, T & Weitz, J 2022, 'Robotic-assisted minimally invasive Ivor Lewis esophagectomy within the prospective multicenter German da Vinci Xi registry trial', LANGENBECK ARCH SURG, vol. 407, no. 4, pp. 1-11. https://doi.org/10.1007/s00423-022-02520-w

APA

Egberts, J-H., Welsch, T., Merboth, F., Korn, S., Praetorius, C., Stange, D. E., Distler, M., Biebl, M., Pratschke, J., Nickel, F., Müller-Stich, B., Perez, D., Izbicki, J. R., Becker, T., & Weitz, J. (2022). Robotic-assisted minimally invasive Ivor Lewis esophagectomy within the prospective multicenter German da Vinci Xi registry trial. LANGENBECK ARCH SURG, 407(4), 1-11. https://doi.org/10.1007/s00423-022-02520-w

Vancouver

Egberts J-H, Welsch T, Merboth F, Korn S, Praetorius C, Stange DE et al. Robotic-assisted minimally invasive Ivor Lewis esophagectomy within the prospective multicenter German da Vinci Xi registry trial. LANGENBECK ARCH SURG. 2022 Jun;407(4):1-11. https://doi.org/10.1007/s00423-022-02520-w

Bibtex

@article{96745abacb844102ab4719cdc99cc000,
title = "Robotic-assisted minimally invasive Ivor Lewis esophagectomy within the prospective multicenter German da Vinci Xi registry trial",
abstract = "PURPOSE: Robotic-assisted minimally invasive esophagectomy (RAMIE) has become one standard approach for the operative treatment of esophageal tumors at specialized centers. Here, we report the results of a prospective multicenter registry for standardized RAMIE.METHODS: The German da Vinci Xi registry trial included all consecutive patients who underwent RAMIE at five tertiary university centers between Oct 17, 2017, and Jun 5, 2020. RAMIE was performed according to a standard technique using an intrathoracic circular stapled esophagogastrostomy.RESULTS: A total of 220 patients were included. The median age was 64 years. Total minimally invasive RAMIE was accomplished in 85.9%; hybrid resection with robotic-assisted thoracic approach was accomplished in an additional 11.4%. A circular stapler size of ≥28 mm was used in 84%, and the median blood loss and operative time were 200 (IQR: 80-400) ml and 425 (IQR: 335-527) min, respectively. The rate of anastomotic leakage was 13.2% (n=29), whereas the two centers with >70 cases each had rates of 7.0% and 12.0%. Pneumonia occurred in 19.5% of patients, and the 90-day mortality was 3.6%. Cumulative sum analysis of the operative time indicated the end of the learning curve after 22 cases.CONCLUSIONS: High-quality multicenter registry data confirm that RAMIE is a safe procedure and can be reproduced with acceptable leak rates in a multicenter setting. The learning curve is comparably low for experienced robotic surgeons.",
keywords = "Esophageal Neoplasms/pathology, Esophagectomy/methods, Humans, Middle Aged, Minimally Invasive Surgical Procedures/methods, Prospective Studies, Registries, Robotic Surgical Procedures/methods",
author = "Jan-Hendrik Egberts and Thilo Welsch and Felix Merboth and Sandra Korn and Christian Praetorius and Stange, {Daniel E} and Marius Distler and Matthias Biebl and Johann Pratschke and Felix Nickel and Beat M{\"u}ller-Stich and Daniel Perez and Izbicki, {Jakob R} and Thomas Becker and J{\"u}rgen Weitz",
note = "{\textcopyright} 2022. The Author(s).",
year = "2022",
month = jun,
doi = "10.1007/s00423-022-02520-w",
language = "English",
volume = "407",
pages = "1--11",
journal = "LANGENBECK ARCH SURG",
issn = "1435-2443",
publisher = "Springer",
number = "4",

}

RIS

TY - JOUR

T1 - Robotic-assisted minimally invasive Ivor Lewis esophagectomy within the prospective multicenter German da Vinci Xi registry trial

AU - Egberts, Jan-Hendrik

AU - Welsch, Thilo

AU - Merboth, Felix

AU - Korn, Sandra

AU - Praetorius, Christian

AU - Stange, Daniel E

AU - Distler, Marius

AU - Biebl, Matthias

AU - Pratschke, Johann

AU - Nickel, Felix

AU - Müller-Stich, Beat

AU - Perez, Daniel

AU - Izbicki, Jakob R

AU - Becker, Thomas

AU - Weitz, Jürgen

N1 - © 2022. The Author(s).

PY - 2022/6

Y1 - 2022/6

N2 - PURPOSE: Robotic-assisted minimally invasive esophagectomy (RAMIE) has become one standard approach for the operative treatment of esophageal tumors at specialized centers. Here, we report the results of a prospective multicenter registry for standardized RAMIE.METHODS: The German da Vinci Xi registry trial included all consecutive patients who underwent RAMIE at five tertiary university centers between Oct 17, 2017, and Jun 5, 2020. RAMIE was performed according to a standard technique using an intrathoracic circular stapled esophagogastrostomy.RESULTS: A total of 220 patients were included. The median age was 64 years. Total minimally invasive RAMIE was accomplished in 85.9%; hybrid resection with robotic-assisted thoracic approach was accomplished in an additional 11.4%. A circular stapler size of ≥28 mm was used in 84%, and the median blood loss and operative time were 200 (IQR: 80-400) ml and 425 (IQR: 335-527) min, respectively. The rate of anastomotic leakage was 13.2% (n=29), whereas the two centers with >70 cases each had rates of 7.0% and 12.0%. Pneumonia occurred in 19.5% of patients, and the 90-day mortality was 3.6%. Cumulative sum analysis of the operative time indicated the end of the learning curve after 22 cases.CONCLUSIONS: High-quality multicenter registry data confirm that RAMIE is a safe procedure and can be reproduced with acceptable leak rates in a multicenter setting. The learning curve is comparably low for experienced robotic surgeons.

AB - PURPOSE: Robotic-assisted minimally invasive esophagectomy (RAMIE) has become one standard approach for the operative treatment of esophageal tumors at specialized centers. Here, we report the results of a prospective multicenter registry for standardized RAMIE.METHODS: The German da Vinci Xi registry trial included all consecutive patients who underwent RAMIE at five tertiary university centers between Oct 17, 2017, and Jun 5, 2020. RAMIE was performed according to a standard technique using an intrathoracic circular stapled esophagogastrostomy.RESULTS: A total of 220 patients were included. The median age was 64 years. Total minimally invasive RAMIE was accomplished in 85.9%; hybrid resection with robotic-assisted thoracic approach was accomplished in an additional 11.4%. A circular stapler size of ≥28 mm was used in 84%, and the median blood loss and operative time were 200 (IQR: 80-400) ml and 425 (IQR: 335-527) min, respectively. The rate of anastomotic leakage was 13.2% (n=29), whereas the two centers with >70 cases each had rates of 7.0% and 12.0%. Pneumonia occurred in 19.5% of patients, and the 90-day mortality was 3.6%. Cumulative sum analysis of the operative time indicated the end of the learning curve after 22 cases.CONCLUSIONS: High-quality multicenter registry data confirm that RAMIE is a safe procedure and can be reproduced with acceptable leak rates in a multicenter setting. The learning curve is comparably low for experienced robotic surgeons.

KW - Esophageal Neoplasms/pathology

KW - Esophagectomy/methods

KW - Humans

KW - Middle Aged

KW - Minimally Invasive Surgical Procedures/methods

KW - Prospective Studies

KW - Registries

KW - Robotic Surgical Procedures/methods

U2 - 10.1007/s00423-022-02520-w

DO - 10.1007/s00423-022-02520-w

M3 - SCORING: Journal article

C2 - 35501604

VL - 407

SP - 1

EP - 11

JO - LANGENBECK ARCH SURG

JF - LANGENBECK ARCH SURG

SN - 1435-2443

IS - 4

ER -